Previous studies have suggested that Meg3 functions through the activation of p53, leading to an increase in p53 protein level and stimulated p53-dependent transcription in a variety of cancer cells (Zhou et al., 2007; Lu et al., 2013; Hu et al., 2016; Li et al., 2016). The gene discussed is TP53; the disease is cancer.